The companies will collaborate to integrate the technology into viral clearance services provided by Charles River, which is designed to result in a consistent study outcome for clients.
TrueSpike technology enables removal of cell debris, DNA, and non-viral proteins from virus preparations used to validate biomanufacturing process virus clearance.
EMD services and solutions vice president Christophe Couturier said the partnership with Charles brings together their regulatory and viral clearance experience and extensive knowledge of virus filtration and process engineering.
Charles River biopharmaceutical services corporate vice president Birgit Girshick said the partnership enhances its ability to exceed client expectations by offering a cost effective, innovative solution.